- Home
- ELVN vs ASPN Comparison
ELVN vs ASPN Comparison
Compare ELVN & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- ASPN
- Stock Information
- Founded
- ELVN 2016
- ASPN 2001
- Country
- ELVN United States
- ASPN United States
- Employees
- ELVN N/A
- ASPN N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- ASPN RETAIL: Building Materials
- Sector
- ELVN Health Care
- ASPN Consumer Discretionary
- Exchange
- ELVN Nasdaq
- ASPN Nasdaq
- Market Cap
- ELVN 1.1B
- ASPN 1.1B
- IPO Year
- ELVN 2020
- ASPN 2014
- Fundamental
- Price
- ELVN $21.86
- ASPN $11.54
- Analyst Decision
- ELVN Strong Buy
- ASPN Strong Buy
- Analyst Count
- ELVN 5
- ASPN 10
- Target Price
- ELVN $37.80
- ASPN $30.00
- AVG Volume (30 Days)
- ELVN 220.2K
- ASPN 1.5M
- Earning Date
- ELVN 03-13-2025
- ASPN 02-12-2025
- Dividend Yield
- ELVN N/A
- ASPN N/A
- EPS Growth
- ELVN N/A
- ASPN N/A
- EPS
- ELVN N/A
- ASPN 0.02
- Revenue
- ELVN N/A
- ASPN $413,830,000.00
- Revenue This Year
- ELVN N/A
- ASPN $92.45
- Revenue Next Year
- ELVN N/A
- ASPN $11.22
- P/E Ratio
- ELVN N/A
- ASPN $577.34
- Revenue Growth
- ELVN N/A
- ASPN 93.28
- 52 Week Low
- ELVN $10.90
- ASPN $10.75
- 52 Week High
- ELVN $30.03
- ASPN $33.15
- Technical
- Relative Strength Index (RSI)
- ELVN 44.27
- ASPN 38.06
- Support Level
- ELVN $21.45
- ASPN $11.13
- Resistance Level
- ELVN $22.82
- ASPN $12.90
- Average True Range (ATR)
- ELVN 1.55
- ASPN 0.71
- MACD
- ELVN 0.00
- ASPN -0.03
- Stochastic Oscillator
- ELVN 32.63
- ASPN 12.82
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.